Steven Chao-Huan Chang

Title: The Innovative Contributions of Steven Chao-Huan Chang

Introduction

Steven Chao-Huan Chang, based in Chicago, IL, is a notable inventor with two significant patents to his name. His work primarily focuses on the field of cartilage repair, demonstrating a strong commitment to advancing medical technology that aids in healing and regeneration.

Latest Patents

Chang's latest patents revolve around cartilage-derived morphogenetic proteins. His first patent details nucleotide and amino acid sequences of cartilage-derived morphogenetic proteins (CDMP-1 and CDMP-2) extracted from human and bovine cartilage. These proteins exhibit chondrogenic activity, making them valuable for repairing cartilage defects in mammals. The second patent involves a purified cartilage extract that stimulates local cartilage formation when combined with a matrix and implanted into a mammal. The method described includes obtaining, homogenizing, and separating cartilage tissue proteins, leading to the creation of an extract that can enhance cartilage healing.

Career Highlights

Chang is currently affiliated with the Government of the United States of America, specifically represented by the Secretary of the Department of Health and Human Services. His ongoing research and contributions to the field of biomedical science underscore the innovative spirit that propels his career.

Collaborations

Throughout his career, Chang has collaborated with esteemed colleagues such as Frank P. Luyten and Malcolm Moos, Jr. These partnerships have likely enriched his research endeavors, allowing for a multidisciplinary approach to solving complex medical challenges.

Conclusion

Steven Chao-Huan Chang's work in the realm of cartilage regeneration and repair not only represents his innovative capabilities but also showcases the potential for future advancements in medical treatments. His patents provide a foundation for further research and development in regenerative medicine, making a lasting impact on healthcare.